Ke Yang
Impact in
- Cancer Research top 5%
- Carcinogens and Genotoxicity Assessment
- Hematology top 5%
- Platelet Disorders and Treatments
Papers in
- Hematology 14
- Platelet Disorders and Treatments 8
- Immunology 14
- Co-authors
- Dennis W. Stacey (5 shared papers)Masahiro Hitomi (5 shared papers)Kari Hemminki (9 shared papers)Roger R. Reddel (3 shared papers)John F. Lechner (3 shared papers)Curtis C. Harris (3 shared papers)Mary G. McMenamin (2 shared papers)Brenda I. Gerwin (2 shared papers)
- Journals
- Scientific Reports (5 papers)Carcinogenesis (3 papers)Oncogene (2 papers)Annals of Hematology (2 papers)Viruses (2 papers)
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Ke Yang
80 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 129
- Cancer Research 392
- Hematology 173
- Oncology 395
- Molecular Biology 1.0k
- Immunology 297
Countries citing papers authored by Ke Yang
This map shows the geographic impact of Ke Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Yang more than expected).
Fields of papers citing papers by Ke Yang
This network shows the impact of papers produced by Ke Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Yang. The network helps show where Ke Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ke Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 88 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 203 | |
| 2 | 2006 | 191 | |
| 3 | 1988 | 164 | |
| 4 | 2014 | 145 | |
| 5 | Establishment of a human in vitro mesothelial cell model system for investigating mechanisms of asbestos-induced mesothelioma. | 1989 | 127 |
| 6 | Biomarkers of polycyclic aromatic hydrocarbon-DNA damage and cigarette smoke exposures in paired maternal and newborn blood samples as a measure of differential susceptibility. | 2001 | 90 |
| 7 | 2005 | 81 | |
| 8 | 2005 | 75 | |
| 9 | 2008 | 59 | |
| 10 | Development of tumorigenicity in simian virus 40-immortalized human bronchial epithelial cell lines. | 1993 | 57 |
| 11 | 2005 | 57 | |
| 12 | 2006 | 50 | |
| 13 | 2006 | 48 | |
| 14 | 2020 | 46 | |
| 15 | 1999 | 45 | |
| 16 | 2001 | 45 | |
| 17 | 1995 | 41 | |
| 18 | 2015 | 39 | |
| 19 | 1994 | 38 | |
| 20 | Differential interactions between GSTM1 and NAT2 genotypes on aromatic DNA adduct level and HPRT mutant frequency in lung cancer patients and population controls. | 2001 | 34 |
About Ke Yang
Ke Yang is a scholar working on Hematology, Immunology, Oncology, Cancer Research and Molecular Biology, having authored 88 papers that have together received 2.4k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (8 papers), Carcinogens and Genotoxicity Assessment (6 papers), RNA modifications and cancer (5 papers), Cancer-related Molecular Pathways (5 papers), SARS-CoV-2 and COVID-19 Research (5 papers), DNA Repair Mechanisms (4 papers), Hepatitis B Virus Studies (4 papers) and Epigenetics and DNA Methylation (4 papers). The work is most often cited by research in Cancer Research (392 citations), Hematology (173 citations), Oncology (395 citations), Molecular Biology (1.0k citations) and Immunology (297 citations). Ke Yang has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Dennis W. Stacey, Masahiro Hitomi, Kari Hemminki, Roger R. Reddel, John F. Lechner, Curtis C. Harris, Mary G. McMenamin, Brenda I. Gerwin, Masao Miyashita and Yaqi Pan. Their work appears in journals such as Scientific Reports, Carcinogenesis, Oncogene, Annals of Hematology and Viruses.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.